Yuandong Biotech (688513.SH) disclosed its 2023 annual report. The company achieved revenue of 1,117 billion yuan in 2023, a year-on-year decrease of 4.56%; net profit to mother was 227 million yuan, a year-on-year decrease of 8.09%; after deducting non-net profit of 158 million yuan, a year-on-year decrease of 4.32%. Basic earnings per share were $1.89. It is proposed to distribute a cash dividend of 5.8 yuan (tax included) for every 10 shares, and the capital reserve will be used to transfer 4.7 shares for every 10 shares to all shareholders.
苑东生物(688513.SH)发布2023年度业绩，净利润2.27亿元，同比下降8.09%
Yuandong Biotech (688513.SH) announced its 2023 annual results, with net profit of 227 million yuan, a year-on-year decrease of 8.09%
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.